Sign inSign in
ConceptMedicine

Vorasidenib

An IDH1 and IDH2 mutant inhibitor approved by the FDA in 2024 for low-grade gliomas.
as Guneet Sarai defines itUniversity of Louisville
Watch it explained

Know first

Named as a prerequisite by the lectures that define this. The number is how many say so. A grey one has no page yet.

2-Hydroxyglutarate1IDH mutation1IDH-mutant gliomas1Low-grade glioma1

Lecturers

1

    Connections

    3

    The lectures that define it or assume it, and the concepts next to it.

    Concepts2

    1 lecturer. Definitions are written by AI from each lecture’s transcript. A time with a play mark starts the lecture at the moment the lecturer says it.